NeoVentures Timeline
Protein Production
Added in-house recombinant protein production
Analysis
Added capacity in transcriptomics analysis of the effect of aptamers on cell lines
Meta-Analysis
Creation of system for meta-analysis of aptamer selection
Neomer Method
Invention of Neomer method of aptamer selection, a game-changing selection platform (patents filed on method and method of analysis)
COVID Aptamers
Development of a catalogue of COVID aptamers
Aptamer Applications
Development of aptamer applications with electrochemical techniques
Method Invention
The invention of method to select aptamers that induce endocytosis for drug delivery
Fluorescence Switching
Development of aptamer efficacy with fluorescence switching in the presence of graphene oxide
Gold
Development of aptamer gold nanoparticle applications, lateral flow, flow through
Aptamer Selection
The invention of method to select aptamers that do not induce endocytosis on transmembrane receptors, prophylactic applications
Development
Development of aptamer quantum dot applications
Barcelona
Development of Barcelona method, while flying to Barcelona, for multiple target selection
Aptamarker Platform
NeoNeuro invents and patents the aptamarker platform, an agnostic approach for the identification of aptamers that bind to diagnostically meaningful targets
BBB
The invention of BBB aptamers, pre-selected for capacity to penetrate the blood-brain barrier
Paris, France
Founded NeoNeuro in Paris for the development of aptamer applications for neurodegenerative disease treatment and diagnosis
FRELEX
Patented FRELAX, an aptamer selection method for small molecules in a free state
Software Development
Developed NGS software. The first company to provide NGS service for aptamer discovery
Aptamer Development
Launch of fee-for-service aptamer development services
Commercial Launch
Follow up with the commercial launch of Rising Number test, an aptamer-based test for dough quality
Commercialization
First commercialization of an aptamer based diagnostic, the MycoSense series of products
Development
First successful Aptamers for small molecules Ochratoxin A & Aflatoxin B1 were developed
NeoVenture Biotechnology Inc.
Incorporates in Canada
